Document | Year | Terms |
---|---|---|
News • 01/23/2023 | Press releases | Share buyback Programs Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHFDownload PDF | ||
News • 01/04/2023 | Outstanding shares and voting rights statements Monthly information regarding the total number of voting rights and total number of shares of the Company as of December 31, 2022Download PDF | ||
News • 12/23/2022 | Press releases DBV Technologies Announces FDA Has Lifted Partial Clinical Hold on VITESSE Phase 3 Pivotal TrialDownload PDF | ||
News • 12/08/2022 | Outstanding shares and voting rights statements Monthly information regarding the total number of voting rights and total number of shares of the Company as of November 30, 2022Download PDF | ||
News • 11/03/2022 | Press releases | Quarterly financial information DBV Technologies Reports Third Quarter Financial Results and Business UpdateDownload PDF |
Document | Year | Terms |
---|---|---|
News • 06/09/2022 | Corporate Amendment to the 2021 URDDownload PDF | ||
News • 06/09/2022 | Corporate | Finance Securities Note – 2022Download PDF | ||
News • 05/12/2022 | General Assembly DBV Technologies Announces Results of Its 2022 Ordinary and Extraordinary General MeetingDownload PDF | ||
News • 04/26/2022 | General Assembly AGM 2022 – Annual ReportDownload PDF | ||
News • 04/26/2022 | General Assembly AGM 2022 – Definitive Proxy StatementDownload PDF |